vimarsana.com
Home
Live Updates
Altimmune, Inc. (NASDAQ:ALT) Q2 2023 Earnings Call Transcrip
Altimmune, Inc. (NASDAQ:ALT) Q2 2023 Earnings Call Transcrip
Altimmune, Inc. (NASDAQ:ALT) Q2 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Altimmune, Inc. Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Related Keywords
United States ,
Scot Roberts ,
Jon Wolleben ,
Seamus Fernandez ,
Scott Harris ,
Louis Aronne ,
Yasmeen Rahimi ,
Patrick Trucchio ,
Corinne Jenkins ,
Boehringer Ingelheim Zealand ,
Vipin Garg ,
Stephen Harrison ,
Louis Susser ,
Piper Sandler ,
Mayank Mamtani ,
Oxford University ,
Nasdaq ,
Goldman Sachs ,
Weill Cornell Medical School ,
Pinnacle Research ,
Altimmune Inc ,
Call Transcript August ,
Second Quarter ,
Results Conference ,
Rich Eisenstadt ,
Chief Financial Officer ,
Chief Executive Officer ,
Chief Scientific Officer ,
Chief Medical ,
Investor Relations ,
Private Securities Litigation Reform Act ,
Chief Executive ,
Chief Medical Officer ,
Medical Director ,
Roger Song ,